Treatment effect differences
Estimated treatment effects for both outcomes according to the variables assessed are presented in Figure Between‐group differences in outcomes according to various baseline characteristics. Differences in days alive without life support (DAWOLS) and mortality at Day 90 with 95% confidence intervals according to the variables assessed at baseline (including predicted risks of mortality at Day 90 using the internal prediction model) with 95% confidence intervals. Values are presented as the treatment effects of 12‐mg dexamethasone, that is, positive differences indicate higher values in the 12‐mg group and vice versa. For both outcomes, predicted values and 95% confidence intervals are truncated at the lowest/highest possible values (0/90 days and 0/100%, respectively). The 